Fusion Antibodies PLC (FAB)

Currency in GBP
10.25
-1.00(-8.89%)
Closed·
FAB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10.1111.50
52 wk Range
9.0020.00
Key Statistics
Bid/Ask
10.00 / 11.00
Prev. Close
10.25
Open
11.25
Day's Range
10.11-11.5
52 wk Range
9-20
Volume
471.18K
Average Volume (3m)
361.12K
1-Year Change
-33.871%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FAB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Fusion Antibodies PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
Sep 03, 2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
1.27M / 1.41M
EPS Revisions
Last 90 days

FAB Income Statement

Compare FAB to Peers and Sector

Metrics to compare
FAB
Peers
Sector
Relationship
P/E Ratio
−11.2x−4.2x−0.3x
PEG Ratio
−0.27−0.030.00
Price/Book
7.9x4.0x2.6x
Price / LTM Sales
6.1x7.4x3.0x
Upside (Analyst Target)
-120.1%58.2%
Fair Value Upside
Unlock3.5%7.5%Unlock

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing and engineering, antibody humanization and rational affinity maturation platform, recombinant protein expressions, and stable cell line development and cGMP scale up services. Its products are used in the pharmaceutical, biotech, veterinary, diagnostic, and life science research companies. The company has a collaboration agreement with the National Cancer Institute for the use of OptiMAL. Fusion Antibodies plc was incorporated in 2000 and is based in Belfast, the United Kingdom.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
7.44M5.95%837.25K
Other Institutional Investors
78.56M62.77%8.84M
Public Companies & Retail Investors
39.16M31.29%4.41M
Total
125.16M100.00%14.08M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Hargreaves Lansdown Asset Management Ltd.16.79%21,013,7542,364
Canaccord Genuity Wealth (International) Ltd.9.08%11,368,1051,279

People Also Watch

0.045
EMEL
-2.17%
0.16
BZT
-5.88%
0.68
ALRT
-2.86%
0.1350
NFXN
0.00%
0.1350
VALX
0.00%

FAQ

What Is the Fusion Antibodies (FAB) Stock Price Today?

The Fusion Antibodies stock price today is 10.25 GBP.

What Stock Exchange Does Fusion Antibodies Trade On?

Fusion Antibodies is listed and trades on the London Stock Exchange.

What Is the Stock Symbol for Fusion Antibodies?

The stock symbol for Fusion Antibodies is "FAB."

What Is the Fusion Antibodies Market Cap?

As of today, Fusion Antibodies market cap is 12.83M GBP.

What Is Fusion Antibodies's Earnings Per Share (TTM)?

The Fusion Antibodies EPS (TTM) is -0.01.

When Is the Next Fusion Antibodies Earnings Date?

Fusion Antibodies will release its next earnings report on Dec 07, 2026.

From a Technical Analysis Perspective, Is FAB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Fusion Antibodies Stock Split?

Fusion Antibodies has split 0 times.

How Many Employees Does Fusion Antibodies Have?

Fusion Antibodies has 27 employees.

What is the current trading status of Fusion Antibodies (FAB)?

As of Oct 07, 2026, Fusion Antibodies (FAB) is trading at a price of 10.25 GBP, with a previous close of 10.25 GBP. The stock has fluctuated within a day range of 10.11 GBP to 11.50 GBP, while its 52-week range spans from 9.00 GBP to 20.00 GBP.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.